{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:11:18Z","timestamp":1769163078170,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jinf.2017.04.011","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T15:17:02Z","timestamp":1493997422000},"page":"132-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9758-867X","authenticated-orcid":false,"given":"Vanessa","family":"Clifford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Tebruegge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Zufferey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susie","family":"Germano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"McBryde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damon","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Robins-Browne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Street","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Denholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2017.04.011_bib1","series-title":"Global plan to end TB: 2016-2020","author":"Stop TB Partnership","year":"2015"},{"key":"10.1016\/j.jinf.2017.04.011_bib2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijid.2014.11.020","article-title":"Tuberculosis elimination in the post Millennium Development Goals era","volume":"32","author":"Wejse","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jinf.2017.04.011_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tube.2015.01.003","article-title":"Cytokines for monitoring anti-tuberculous therapy: a systematic review","volume":"95","author":"Clifford","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jinf.2017.04.011_bib4","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1183\/09031936.00151413","article-title":"Beyond the IFN-gamma horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis","volume":"43","author":"Chegou","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2017.04.011_bib5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/INF.0000000000000796","article-title":"Diagnostic tests for childhood tuberculosis: past imperfect, present tense and future perfect?","volume":"34","author":"Tebruegge","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jinf.2017.04.011_bib6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1473-3099(13)70008-2","article-title":"Advances in tuberculosis diagnostics: the Xpert MTB\/RIF assay and future prospects for a point-of-care test","volume":"13","author":"Lawn","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2017.04.011_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2016.11.010","article-title":"Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease","volume":"74","author":"Won","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2017.04.011_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152483","article-title":"Combined analysis of IFN-gamma, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT supernatant is useful for distinguishing active tuberculosis from latent infection","volume":"11","author":"Suzukawa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2017.04.011_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1164\/rccm.201501-0059OC","article-title":"Mycobacteria-specific cytokine responses detect tuberculosis infection and distinguish latent from active\u00a0tuberculosis","volume":"192","author":"Tebruegge","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2017.04.011_bib10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tube.2011.02.006","article-title":"Discriminating between latent and active tuberculosis with multiple biomarker responses","volume":"91","author":"Frahm","year":"2011","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jinf.2017.04.011_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000283687","article-title":"Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis","volume":"80","author":"Eum","year":"2010","journal-title":"Respiration"},{"key":"10.1016\/j.jinf.2017.04.011_bib12","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1128\/CVI.05037-11","article-title":"Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with pulmonary tuberculosis","volume":"18","author":"Bertholet","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2017.04.011_bib13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nm.2299","article-title":"Dominant TNF-+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease","volume":"17","author":"Harari","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2017.04.011_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2249.2009.03875.x","article-title":"Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis","volume":"156","author":"Djoba Siawaya","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2017.04.011_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tube.2015.07.002","article-title":"Interferon gamma release assays for monitoring the response to treatment for tuberculosis: a systematic review","volume":"95","author":"Clifford","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jinf.2017.04.011_bib16","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.clinthera.2012.03.006","article-title":"Utility of interferon- release assay results to monitor anti-tubercular treatment in adults and children","volume":"34","author":"Chiappini","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.jinf.2017.04.011_bib17","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1378\/chest.99.5.1172","article-title":"A 19-year follow-up of tuberculin reactors. Assessment of skin test reactivity and in\u00a0vitro lymphocyte responses","volume":"99","author":"Havlir","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2017.04.011_bib18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1164\/rccm.201402-0363PP","article-title":"Getting personal perspectives on individualized treatment duration in multidrug-resistant and extensively drug-resistant tuberculosis","volume":"190","author":"Heyckendorf","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2017.04.011_bib19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jinf.2015.08.001","article-title":"Serum IP-10 in the diagnosis of latent and active tuberculosis","volume":"71","author":"Clifford","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2017.04.011_bib20","series-title":"Management, control and prevention of tuberculosis: guidelines for health care providers","author":"Department of Health & Human Services","year":"2015"},{"key":"10.1016\/j.jinf.2017.04.011_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-0500-2-19","article-title":"IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay","volume":"2","author":"Ruhwald","year":"2009","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jinf.2017.04.011_bib22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cyto.2012.12.031","article-title":"Multiplex analysis of cytokines\/chemokines as biomarkers that differentiate healthy contacts from tuberculosis patients in high endemic settings","volume":"61","author":"Anbarasu","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.jinf.2017.04.011_bib23","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2017.04.011_bib24","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.4049\/jimmunol.156.7.2503","article-title":"IL-1 receptor antagonist (IL-1ra) expression, function, and cytokine-mediated regulation during mycobacterial and schistosomal antigen-elicited granuloma formation","volume":"156","author":"Ruth","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2017.04.011_bib25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/506935","article-title":"Antirheumatic drugs and the risk of tuberculosis","volume":"43","author":"Brassard","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2017.04.011_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/RHU.0b013e31812e00a1","article-title":"Reactivation of pulmonary tuberculosis in a patient with rheumatoid arthritis during treatment with IL-1 receptor antagonists (anakinra)","volume":"13","author":"Settas","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jinf.2017.04.011_bib27","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1164\/ajrccm.157.4.9709126","article-title":"Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis","volume":"157","author":"Juffermans","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2017.04.011_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3904\/kjim.2003.18.3.138","article-title":"Changes of plasma interleukin-1 receptor antagonist, interleukin-8 and other serologic markers during chemotherapy in patients with active pulmonary tuberculosis","volume":"18","author":"Lee","year":"2003","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jinf.2017.04.011_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.tube.2015.02.039","article-title":"The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB gold in tube assays","volume":"95","author":"Clifford","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jinf.2017.04.011_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jinf.2013.02.004","article-title":"IFN\/TNFalpha specific-cells and effector memory phenotype associate with active tuberculosis","volume":"66","author":"Petruccioli","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2017.04.011_bib31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/cytob.21110","article-title":"Comparative analysis of whole-blood interferon-gamma and flow cytometry assays for detecting post-treatment immune responses in patients with active tuberculosis","volume":"86","author":"Kim","year":"2014","journal-title":"Cytom B Clin Cytom"},{"key":"10.1016\/j.jinf.2017.04.011_bib32","article-title":"Mycobacterium tuberculosis-specific TNF-alpha is a potential biomarker for the rapid diagnosis of active tuberculosis disease in Chinese population","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2017.04.011_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012365","article-title":"Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort","volume":"5","author":"Sutherland","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2017.04.011_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.smim.2014.10.002","article-title":"Perspectives on host adaptation in response to Mycobacterium tuberculosis: modulation of inflammation","volume":"26","author":"Dorhoi","year":"2014","journal-title":"Semin Immunol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445317301317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445317301317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:24:20Z","timestamp":1759008260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445317301317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0163445317301317"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2017.04.011","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2017.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}